Promoting evidence-based management of anemia in cancer patients: Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines-Reference-Cited by-同舟云学术

Promoting evidence-based management of anemia in cancer patients: Background, development, and scientific validation of RESPOND, a web-based clinical guidance system based on the EORTC guidelines

Published:2008-01 Issue:1 Volume:65 Page:32-42
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Aapro Matti,Van Erps Joanna,MacDonald Karen,Soubeyran Pierre,Turner Matthew,Muenzberg Michael,Dunlop Robert,Warrinnier Hans,Abraham Ivo

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference23 articles.

1. Chemotherapy-induced anemia in adults: incidence and treatment;Groopman;J Natl Cancer Inst,1999

2. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anemia in cancer patients;Ludwig;Eur J Cancer,2004

3. Anemia of chronic disease;Weiss;New Engl J Med,2005

5. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review;Caro;Cancer,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What do prescribers think of biosimilars?;Targeted Oncology;2012-01-19

2. What does a prescriber think of biosimilars?;Oncologie;2011-05

3. Promoting evidence-based management of anemia in cancer patients: concurrent and discriminant validity of RESPOND, a web-based clinical guidance system based on the EORTC guidelines for supportive care in cancer;Supportive Care in Cancer;2009-11-11

4. Managing cancer-related anaemia in congruence with the EORTC guidelines is an independent predictor of haemoglobin outcome: Initial evidence from the RESPOND study;European Journal of Cancer;2009-01